nad has been researched along with quercetin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, MR; O'Brien, MM; Schofield, PJ | 1 |
| Katsura, H; Kitamura, S; Tatsumi, K | 1 |
| Nakamoto, N; Toki, S; Yamano, S | 1 |
| Kitson, KE; Kitson, TM | 1 |
| Atalla, A; Breyer-Pfaff, U; Maser, E | 1 |
| Kitson, KE; Kitson, TM; Moore, SA | 1 |
| Reidenberg, MM; Shi, H; Wang, KS; Wang, MS | 1 |
| Bracht, A; Buss, GD; Comar, JF; Constantin, J; de Lima, LC; Ishii-Iwamoto, EL; Teodoro, GR | 1 |
| Boddy, AV; Jamieson, D; Knox, RJ; Tung, AT | 1 |
| Briedé, JJ; Kleinjans, JC; Moonen, EJ; Wilms, LC | 1 |
| Cho, SW; Choi, MM; Choi, SY; Hong, HN; Huh, JW; Hwang, EY | 1 |
| Lang, DR; Racker, E | 1 |
| Heinzle, E; Niklas, J; Nonnenmacher, Y; Rose, T; Sandig, V | 1 |
| Aliaga, ME; Lopez-Alarcón, C; Sandoval-Acuña, C; Speisky, H | 1 |
| Dilgin, DG; Dilgin, Y; Gökçel, Hİ; Gorton, L; Kızılkaya, B | 1 |
| Barbosa, MT; Capellini, V; Chini, EN; Escande, C; Gomes, AP; Nin, V; O'Neil, L; Price, NL; Sinclair, DA; White, TA | 1 |
| Babes, R; Baran, I; Dimancea, A; Filippi, A; Ganea, C; Goicea, A; Iftime, A; Ionescu, D; Irimia, R; Mocanu, MM; Neagu, A; Popescu, V; Tofolean, IT | 1 |
| Bast, A; Boesten, DM; den Hartog, GJ; von Ungern-Sternberg, SN | 1 |
| Areti, A; Gogoi, R; Komirishetty, P; Kumar, A; Sistla, R | 1 |
| Heger, V; Horáková, L; Hunyadi, A; Lahtela-Kakkonen, M; Rahnasto-Rilla, M; Tyni, J | 1 |
| Jia, BX; Liu, N; Wu, A; Yang, YX; Yu, S | 1 |
21 other study(ies) available for nad and quercetin
| Article | Year |
|---|---|
Polyol-pathway enzymes of human brain. Partial purification and properties of sorbitol dehydrogenase.
Topics: Brain; Brain Chemistry; Electrophoresis, Polyacrylamide Gel; Galactitol; Hot Temperature; Humans; Hydrogen-Ion Concentration; Kinetics; L-Iditol 2-Dehydrogenase; NAD; Quercetin; Sorbitol; Substrate Specificity; Sugar Alcohol Dehydrogenases; Sulfhydryl Reagents | 1983 |
Purification of a 15-ketoprostaglandin delta 13-reductase from rat liver and its ability to reduce the double bond of xenobiotics.
Topics: 15-Oxoprostaglandin 13-Reductase; Animals; Chloromercuribenzoates; Cytosol; Dicumarol; Dinoprost; Hydrogen-Ion Concentration; Indomethacin; Isoelectric Focusing; Liver; Male; Molecular Weight; NAD; NADP; Oxidation-Reduction; p-Chloromercuribenzoic Acid; Quercetin; Rats; Rats, Wistar; Xenobiotics | 1993 |
Purification and characterization of rat liver naloxone reductase that is identical to 3alpha-hydroxysteroid dehydrogenase.
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); 3-Hydroxysteroid Dehydrogenases; Alcohol Oxidoreductases; Amino Acid Sequence; Animals; Cytosol; Enzyme Inhibitors; Enzyme Stability; Ethylmaleimide; Indomethacin; Liver; Male; Molecular Sequence Data; NAD; NADP; Naloxone; p-Chloromercuribenzoic Acid; Quercetin; Rats; Rats, Wistar; Sequence Analysis, Protein | 1999 |
The effect of quercetin, a widely distributed flavonoid in food and drink, on cytosolic aldehyde dehydrogenase: a comparison with the effect of diethylstilboestrol.
Topics: Aldehyde Dehydrogenase; Animals; Cytosol; Diethylstilbestrol; Kinetics; Liver; Molecular Structure; NAD; Quercetin; Sheep; Spectrophotometry; Spectrophotometry, Ultraviolet | 2000 |
Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adult; Aged; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Carcinogens; Cytosol; Enzyme Inhibitors; Female; Flufenamic Acid; Humans; Hydroxysteroid Dehydrogenases; Liver; Male; Medroxyprogesterone Acetate; Middle Aged; NAD; NADP; Nicotiana; Nitrosamines; Phenolphthalein; Plants, Toxic; Quercetin; Rutin; Smoke; Vitamin K | 2000 |
Interaction of sheep liver cytosolic aldehyde dehydrogenase with quercetin, resveratrol and diethylstilbestrol.
Topics: Aldehyde Dehydrogenase; Animals; Binding Sites; Catalytic Domain; Cytosol; Diethylstilbestrol; Enzyme Activation; Enzyme Inhibitors; In Vitro Techniques; Kinetics; Liver; Models, Molecular; NAD; Protein Conformation; Quercetin; Resveratrol; Sheep; Stilbenes | 2001 |
Inhibition of 11beta-hydroxysteroid dehydrogenase in guinea pig kidney by three bioflavonoids and their interactions with gossypol.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Depression, Chemical; Drug Synergism; Enzyme Inhibitors; Flavones; Flavonoids; Gossypol; Guinea Pigs; Hydroxysteroid Dehydrogenases; Hypokalemia; Male; NAD; Quercetin | 2002 |
The action of quercetin on the mitochondrial NADH to NAD(+) ratio in the isolated perfused rat liver.
Topics: Animals; Liver; Mitochondria; NAD; Oxygen; Perfusion; Quercetin; Rats | 2005 |
Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
Topics: Alkylating Agents; Animals; Aziridines; Catalysis; Cell Line; Comet Assay; Electron Transport; Humans; Mitomycin; NAD; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Quercetin; Quinone Reductases; Recombinant Proteins; Transfection | 2006 |
Discriminative protection against hydroxyl and superoxide anion radicals by quercetin in human leucocytes in vitro.
Topics: Adult; Antioxidants; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Female; Humans; Hydroxyl Radical; In Vitro Techniques; Iron; Kinetics; Leukocytes; Male; NAD; Oxidants; Quercetin; Superoxides | 2008 |
Inhibitory effects of gallic acid and quercetin on UDP-glucose dehydrogenase activity.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Gallic Acid; Humans; NAD; Quercetin; Uridine Diphosphate Glucose; Uridine Diphosphate Glucose Dehydrogenase | 2008 |
Effects of quercetin and F1 inhibitor on mitochondrial ATPase and energy-linked reactions in submitochondrial particles.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Cattle; Mitochondria, Heart; Mitochondrial Proton-Translocating ATPases; Molecular Structure; NAD; Oxidation-Reduction; Oxidative Phosphorylation; Quercetin; Rutamycin; Succinic Acid; Uncoupling Agents | 1974 |
Quercetin treatment changes fluxes in the primary metabolism and increases culture longevity and recombinant α₁-antitrypsin production in human AGE1.HN cells.
Topics: alpha 1-Antitrypsin; Biological Transport; Cell Line, Transformed; Cell Survival; Cells; Citric Acid Cycle; Glucose; Humans; NAD; Pyruvic Acid; Quercetin | 2012 |
Inhibition of mitochondrial complex I by various non-steroidal anti-inflammatory drugs and its protection by quercetin via a coenzyme Q-like action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Caco-2 Cells; Diclofenac; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electron Transport Complex I; Humans; Ibuprofen; Indomethacin; Mitochondria; Multienzyme Complexes; NAD; Piroxicam; Protective Agents; Quercetin; Rats; Ubiquinone | 2012 |
Electrocatalytic oxidation of NADH using a pencil graphite electrode modified with quercetin.
Topics: Electrochemistry; Electrodes; Graphite; NAD; Oxidation-Reduction; Quercetin | 2013 |
Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.
Topics: ADP-ribosyl Cyclase 1; Animals; Apigenin; Cell Line, Tumor; Gene Expression Regulation; Humans; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; NAD; Obesity; Quercetin; Random Allocation; Sirtuin 1 | 2013 |
Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells.
Topics: Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Humans; Jurkat Cells; Leukemia; Membrane Potentials; NAD; Quercetin; Reactive Oxygen Species; Rotenone; Vitamin K 3 | 2014 |
Protective Pleiotropic Effect of Flavonoids on NAD⁺ Levels in Endothelial Cells Exposed to High Glucose.
Topics: Aldehyde Reductase; Animals; Apoptosis; Flavones; Flavonoids; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Lens, Crystalline; NAD; Poly(ADP-ribose) Polymerases; Protective Agents; Quercetin; Rutin; Swine | 2015 |
Combination strategy of PARP inhibitor with antioxidant prevent bioenergetic deficits and inflammatory changes in CCI-induced neuropathy.
Topics: 1-Naphthylamine; Adenosine Triphosphate; Animals; Antioxidants; Encephalitis; Hyperalgesia; Male; Mitochondria; NAD; Naphthalimides; Neuralgia; Oxidative Stress; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quercetin; Quinolones; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2017 |
Quercetin based derivatives as sirtuin inhibitors.
Topics: Binding Sites; Humans; Molecular Docking Simulation; NAD; Niacinamide; Polyphenols; Quercetin; Sirtuins | 2019 |
Metabolomic profiling reveals similar cytotoxic effects and protective functions of quercetin during deoxynivalenol- and 15-acetyl deoxynivalenol-induced cell apoptosis.
Topics: Antioxidants; Apoptosis; Cell Line; Cell Survival; DNA, Mitochondrial; Humans; Metabolomics; Mitochondria; NAD; Quercetin; Reactive Oxygen Species; Saccharomyces cerevisiae; Trichothecenes | 2020 |